OneMedNet Corporation (NASDAQ:ONMD) Stock Short Interest Report for September

OneMedNet Corporation (NASDAQ:ONMD) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totaling 113,555 shares, a decrease of 87.7% from the September 15th total of 922,431 shares. Based on an average daily trading volume, of 94,253 shares, the days-to-cover ratio is presently 1.2 days. Approximately 3.8% of the shares of the company are short sold.

OneMedNet Stock Down 10.8%

OneMedNet stock traded down $0.52 during mid-day trading on Friday, hitting $4.30. The company had a trading volume of 24,653 shares, compared to its average volume of 69,688. The business has a fifty day moving average of $6.24 and a 200 day moving average of $7.31. The stock has a market cap of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14. OneMedNet has a 1 year low of $4.30 and a 1 year high of $42.20.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, OneMedNet currently has a consensus rating of “Sell”.

Insider Buying and Selling at OneMedNet

In other news, Director Thomas Kosasa bought 144,927 shares of the business’s stock in a transaction dated Thursday, July 30th. The stock was purchased at an average cost of $6.90 per share, with a total value of $999,996.30. Following the acquisition, the director directly owned 1,853,815 shares in the company, valued at $12,791,323.50. This trade represents a 8.48% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Aaron Green sold 5,000 shares of OneMedNet stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $7.39, for a total transaction of $36,950.00. Following the completion of the transaction, the chief executive officer directly owned 249,638 shares of the company’s stock, valued at $1,844,824.82. The trade was a 1.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 12,667 shares of company stock valued at $86,542. 50.20% of the stock is owned by company insiders.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.